OphthalLogix Intelligence
Subscribe
Sign in
Home
Notes
Archive
About
Latest
Top
May 2026 Policy Delta Log: Five Movements, One Convergence
In May 2026, China’s fund audit reached ophthalmology as its first IOL procurement agreements turned over and the device-renewal rulebook hardened.
Jun 8
•
OphthalLogix Intelligence
China’s First IOL Agreements Lapsed at the End of May. The Renewal Playbook Now Exists, Just Not for Lenses.
China’s first IOL VBP agreements lapsed end-May 2026 with no renewal scheme, even as coronary stents were renewed under GH-HD2026-1.
Jun 2
•
OphthalLogix Intelligence
May 2026
China’s Coronary Stent Just Set the Template for IOL VBP Renewal, and the IOL Framework Is Still Missing
On 13 May 2026, Beijing published the renewal methodology for the first national high-value device VBP. The IOL equivalent is still missing as the first…
May 27
•
OphthalLogix Intelligence
Three compliance signals converged in a single 30-day window in May 2026. The combination is without precedent in China’s IOL market.
China’s 2026 insurance audit names ophthalmology among 15 priority domains. IOL procurement agreements expire within weeks. NHC surgical standards now…
May 19
•
OphthalLogix Intelligence
China’s IOL Agreement Expires in 16 Days. No Renewal Framework Has Been Published.
China’s IOL procurement agreement expires on 30 May 2026. No renewal framework published. 16-day vacuum: what it means for market access and pricing.
May 14
•
OphthalLogix Intelligence
One Month Earlier, Eight Years Later: What China’s 2026 Formulary Consultation Means for Ophthalmology
NHSA’s 2026 formulary introduces pre-submission rights and a commercial insurance dual-track. Three ophthalmology signals before 15 May.
May 12
•
OphthalLogix Intelligence
April 2026: Eight Signals Compressed China’s IOL Market From Both Ends
April 2026: 8 signals compressed China's IOL market. Two mandatory NHC cataract notices in 17 days. Cross-provincial price governance in 4 days.
May 8
•
OphthalLogix Intelligence
China Orders 24 Provinces: The IOL Compliance Mandate That Precedes the Volume Story
NHC’s 17-day gap between cataract standard and county enforcement notice signals a forced compliance reset across 24 provinces and the IOL market.
May 6
•
OphthalLogix Intelligence
China IOL Market Access — A Diagnostic
How China’s three IOL reimbursement regimes work, the hospital P&L, the 4th VBP anchor prices, and two observations on physician behaviour the market…
May 5
•
OphthalLogix Intelligence
4,375 Products, Four Days: What China’s Non-VBP Price Governance Means for the IOL Market
Liaoning’s March 2026 price sweep hit 4,375 non-selected products, including IOL in four days. What cross-provincial linkage means for international…
May 1
•
OphthalLogix Intelligence
April 2026
China’s IOL Procurement List Update: The RMB 9,090 Price Anchor and What Non-Selected Means Now
J&J’s EDOF toric selected at RMB 9,090. Multiple MNC products non-selected. What China’s April 2026 IOL procurement update means for market access.
Apr 28
•
OphthalLogix Intelligence
China Rewrites Its Drug Pricing Rules for the First Time in Eleven Years
China's first national drug pricing framework since 2015 protects innovation from VBP, but device companies need a separate rule before anything…
Apr 24
•
OphthalLogix Intelligence
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
